Drug profile · INN
letermovir
PREVYMIS
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
letermovir (PREVYMIS) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN letermovir
Brand PREVYMIS
Route ORAL
Formulation SOLUTION
ATC code J05
Frequently asked questions
What is letermovir?
letermovir (PREVYMIS) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for letermovir?
PREVYMIS is a marketed brand name for letermovir. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of letermovir?
letermovir has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.